GB1563595A - Halogenoprepnadienes and process for the manufacture thereof - Google Patents
Halogenoprepnadienes and process for the manufacture thereof Download PDFInfo
- Publication number
- GB1563595A GB1563595A GB51695/76A GB5169576A GB1563595A GB 1563595 A GB1563595 A GB 1563595A GB 51695/76 A GB51695/76 A GB 51695/76A GB 5169576 A GB5169576 A GB 5169576A GB 1563595 A GB1563595 A GB 1563595A
- Authority
- GB
- United Kingdom
- Prior art keywords
- acid
- process according
- compounds
- solution
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
- C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
- C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Rheumatology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epoxy Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1615075A CH626632A5 (en) | 1975-12-12 | 1975-12-12 | Process for the preparation of halopregnadienes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1563595A true GB1563595A (en) | 1980-03-26 |
Family
ID=4414834
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB51695/76A Expired GB1563595A (en) | 1975-12-12 | 1976-12-10 | Halogenoprepnadienes and process for the manufacture thereof |
Country Status (19)
| Country | Link |
|---|---|
| JP (1) | JPS5273852A (ja) |
| AT (1) | AT353432B (ja) |
| AU (1) | AU510864B2 (ja) |
| BE (1) | BE849267A (ja) |
| CA (1) | CA1078824A (ja) |
| CH (2) | CH626632A5 (ja) |
| DD (1) | DD128682A5 (ja) |
| DE (1) | DE2655802A1 (ja) |
| DK (1) | DK142326B (ja) |
| ES (2) | ES454119A1 (ja) |
| FR (1) | FR2358152A1 (ja) |
| GB (1) | GB1563595A (ja) |
| HU (1) | HU176936B (ja) |
| IE (1) | IE44512B1 (ja) |
| IL (1) | IL51085A (ja) |
| NL (1) | NL7613711A (ja) |
| NZ (1) | NZ182865A (ja) |
| SE (1) | SE7613919L (ja) |
| ZA (1) | ZA767381B (ja) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT78973A (en) * | 1984-07-25 | 1984-08-01 | Joao Emerico Villax | New preparation process of the 9alpha-fluoro 17,21-acylates or hidroxilades in 17 and 21 chloro-corticosteroid |
-
1975
- 1975-12-12 CH CH1615075A patent/CH626632A5/de not_active IP Right Cessation
-
1976
- 1976-12-09 NL NL7613711A patent/NL7613711A/xx not_active Application Discontinuation
- 1976-12-09 DE DE19762655802 patent/DE2655802A1/de not_active Withdrawn
- 1976-12-09 FR FR7637093A patent/FR2358152A1/fr active Granted
- 1976-12-10 CA CA267,597A patent/CA1078824A/en not_active Expired
- 1976-12-10 NZ NZ182865A patent/NZ182865A/xx unknown
- 1976-12-10 IE IE2699/76A patent/IE44512B1/en unknown
- 1976-12-10 IL IL51085A patent/IL51085A/xx unknown
- 1976-12-10 AT AT914176A patent/AT353432B/de not_active IP Right Cessation
- 1976-12-10 DD DD7600196260A patent/DD128682A5/xx unknown
- 1976-12-10 AU AU20471/76A patent/AU510864B2/en not_active Expired
- 1976-12-10 ES ES454119A patent/ES454119A1/es not_active Expired
- 1976-12-10 GB GB51695/76A patent/GB1563595A/en not_active Expired
- 1976-12-10 HU HU76CI1703A patent/HU176936B/hu unknown
- 1976-12-10 SE SE7613919A patent/SE7613919L/xx unknown
- 1976-12-10 BE BE173137A patent/BE849267A/xx unknown
- 1976-12-10 ZA ZA767381A patent/ZA767381B/xx unknown
- 1976-12-10 DK DK557576AA patent/DK142326B/da unknown
- 1976-12-11 JP JP51149325A patent/JPS5273852A/ja active Pending
-
1977
- 1977-12-29 ES ES465551A patent/ES465551A1/es not_active Expired
-
1980
- 1980-10-27 CH CH799480A patent/CH626094A5/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DK557576A (ja) | 1977-06-13 |
| SE7613919L (sv) | 1977-06-13 |
| ZA767381B (en) | 1977-11-30 |
| FR2358152B1 (ja) | 1982-10-22 |
| AU510864B2 (en) | 1980-07-17 |
| AT353432B (de) | 1979-11-12 |
| NL7613711A (nl) | 1977-06-14 |
| DK142326B (da) | 1980-10-13 |
| JPS5273852A (en) | 1977-06-21 |
| IL51085A0 (en) | 1977-02-28 |
| DK142326C (ja) | 1981-03-09 |
| AU2047176A (en) | 1978-06-15 |
| CA1078824A (en) | 1980-06-03 |
| CH626632A5 (en) | 1981-11-30 |
| HU176936B (hu) | 1981-06-28 |
| IE44512L (en) | 1977-06-12 |
| ES465551A1 (es) | 1978-09-16 |
| CH626094A5 (en) | 1981-10-30 |
| NZ182865A (en) | 1979-06-08 |
| FR2358152A1 (fr) | 1978-02-10 |
| IL51085A (en) | 1980-09-16 |
| BE849267A (fr) | 1977-06-10 |
| ES454119A1 (es) | 1978-03-01 |
| IE44512B1 (en) | 1981-12-30 |
| ATA914176A (de) | 1979-04-15 |
| DD128682A5 (de) | 1977-12-07 |
| DE2655802A1 (de) | 1977-06-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4285937A (en) | Novel androstadiene-17-carboxylic acid esters | |
| CA1234564A (en) | Carboxylic acid esters | |
| JP3292928B2 (ja) | 新規なプレグナ−１，４−ジエン−３，２０−ジオン−１６，１７−アセタール−２１−エステル、その製法および抗炎症用医薬組成物 | |
| US3780177A (en) | 17-butyrate,21-ester derivatives of 6alpha,9alpha-difluoroprednisolone,compositions and use | |
| US4124707A (en) | 7α-Halogeno-3,20-dioxo-1,4-pregnadienes, methods for their manufacture, their use as anti-inflammatory agents, and pharmaceutical formulations useful therefor | |
| US4619921A (en) | Polyhalogeno-steroids | |
| US4172132A (en) | 1,3,5(10),6,8,14-19-Nor-pregnahexaenes, their use as anti-psoriatic agents, and pharmaceutical formulations useful therefor | |
| US4576936A (en) | 6α-Fluoro-9α-chloro-prednisolone 17,21-diesters | |
| US3984544A (en) | Retinoic acid esters of steroids of the pregnane series, their use in the treatment of acne and pharmaceutical formulations useful therefor | |
| US4024131A (en) | 16-Methyl-9α-halo steroid esters, ethers and preparation thereof | |
| GB1563638A (en) | 21-halogenopregnane compounds | |
| GB1563595A (en) | Halogenoprepnadienes and process for the manufacture thereof | |
| US4221786A (en) | Novel halogenopregnadienes and process for the manufacture thereof | |
| US3798216A (en) | 9-fluoro-11beta,21-dihydroxy-16alpha,17-(2-propenylidenedioxy)-pregna-1,4-diene-3,20-dione and derivatives thereof | |
| US2873271A (en) | 1, 4, 17(20)-pregnatrienes | |
| US4185101A (en) | 1,3,5(10),6,8-19-Nor-pregnapentaenes, their use as anti-psoriatic agents, and pharmaceutical formulations useful therefor | |
| EP0000609B1 (en) | Novel 19-nor-pregnahexaenes, process for the preparation thereof, and pharmaceutical compositions containing them | |
| DE2756550C2 (de) | Verfahren zur Herstellung von 3,20-Dioxo-7α-halogen-4-pregnenen und 1,4-Pregnadienen, 3,20-Dioxo-7α-chlor und Brom-1,4-pregnadiene und letztere enthaltende Arzneimittel | |
| KR800000555B1 (ko) | 스테로이드의 레티온산 에스테르의 제조방법 | |
| JPS6150960B2 (ja) | ||
| GB1589585A (en) | 12a-halocorticoids | |
| CS208495B2 (en) | Method of making the alcyesters of the 4-halogen-3-oxo-androsta-1,4-dien beta-carboxyle acid | |
| EP0001308A1 (en) | Novel delta-4,9-pregnane derivatives, their use as progestational and/or ovulation-inhibiting agents and process for their preparation | |
| DE2707346A1 (de) | Neue halogenpregnadiene und verfahren zu ihrer herstellung | |
| JPH04297423A (ja) | 眼疾患治療剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PCNP | Patent ceased through non-payment of renewal fee |